DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Femhrt (Norethindrone / Ethinyl Estradiol) - Speech Disorder - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Speech Disorder (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Femhrt (Norethindrone / Ethinyl Estradiol) where reactions include speech disorder. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Femhrt side effects in 60 year old female

Reported by a consumer/non-health professional from United States on 2011-12-09

Patient: 60 year old female, weighing 73.9 kg (162.6 pounds)

Reactions: Hypohidrosis, Speech Disorder, Balance Disorder, Palpitations, Oedema Peripheral, Hallucination, Dyspnoea, Chest Discomfort, Sensation of Heaviness, Dysgeusia, Ageusia, Visual Impairment, Anosmia, Parosmia, Hypertension, Feeling Abnormal, Sluggishness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Femhrt
    Dosage: 5/1000 ug, qd: 5/100 ug, qod for 1 week: 5/1000 ug, every 2 days for 1 week: 2.5/500 ug, qd, oral
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2004-01-01
    End date: 2011-04-01

Femhrt
    Dosage: 5/1000 ug, qd: 5/100 ug, qod for 1 week: 5/1000 ug, every 2 days for 1 week: 2.5/500 ug, qd, oral
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2011-04-01
    End date: 2011-04-01

Femhrt
    Dosage: 5/1000 ug, qd: 5/100 ug, qod for 1 week: 5/1000 ug, every 2 days for 1 week: 2.5/500 ug, qd, oral
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2011-04-01
    End date: 2011-04-01

Femhrt
    Dosage: 5/1000 ug, qd: 5/100 ug, qod for 1 week: 5/1000 ug, every 2 days for 1 week: 2.5/500 ug, qd, oral
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2011-09-26

Other drugs received by patient: Lipitor; Centrum (Ascorbic Acid, Betacarotene, Colecalciferol, Folic Acid, Mine; Fish OIL; Caltrate (Calcium Carbonate); Lisinopril (Lisinopril Dihydrate)



Possible Femhrt side effects in 60 year old female

Reported by a consumer/non-health professional from United States on 2011-11-23

Patient: 60 year old female, weighing 73.9 kg (162.6 pounds)

Reactions: Dyspnoea, Chest Discomfort, Sensation of Heaviness, Hypohidrosis, Speech Disorder, Palpitations, Balance Disorder, Ageusia, Oedema Peripheral, Visual Impairment, Anosmia, Feeling Abnormal, Hypertension, Sluggishness, Hallucination

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Femhrt
    Dosage: see image
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2011-04-01
    End date: 2011-04-01

Femhrt
    Dosage: see image
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2011-04-01
    End date: 2011-04-01

Femhrt
    Dosage: see image
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2004-01-01
    End date: 2011-04-01

Femhrt
    Dosage: see image
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 2011-09-26

Other drugs received by patient: Centrum (Ascorbic Acid, Betacarotene, Colecalciferol, Folic Acid, Mine; Fish OIL (Fish Oil); Lipitor; Caltrate (Calcium Carbonate); Lisinopril (Lisinopril Dihydrate)

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017